T. Lyons, C. Kekedjian, P. Glaser, C. Ohlin, R. van Eldik, O. Rodriguez, C. Albanese, E Van Keuren, S. Stoll, “Molecular Parameters promoting high relaxivity in cluster-nanocarrier MRI contrast agents”, ACS Appl. Mater. Interfaces 2022, 14, 49521−49531, doi.org:10.1021/acsami.2c1258 4
2021
Neckel ND, Dai H, Hanckel J, Lee Y, Albanese C, Rodriguez O. Skilled reach training enhances robotic gait training to restore overground locomotion following spinal cord injury in rats. Behav Brain Res. 2021;414:113490. doi:10.1016/j.bbr.2021.113490
V. Dahanayake, T. Lyons, B. Kerwin, O. Rodriguez, C. Albanese, E. Parasido, Y. Lee, E. Van Keuren, L. Li, E. Maxey, T. Paunesku, G. Woloschak, S. Stoll, “Paramagnetic Mn8Fe4-co-Polystyrene Nanobeads as a Potential T1-T2 Multimodal Magnetic Resonance Imaging Contrast Agent with In Vivo Studies”, ACS Applied Materials & Interfaces, 13 (2021) 39042-39054. https://doi.org/10.1021/acsami.1c09232
Prasad S, Chandra A, Cavo M, et al. Optical and magnetic resonance imaging approaches for investigating the tumour microenvironment: state-of-the-art review and future trends. Nanotechnology. 2021;32(6):062001. doi:10.1088/1361-6528/abc208
Coia H, Ma N, Hou Y, et al. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet. Clin Nutr. 2021;40(1):110-119. doi:10.1016/j.clnu.2020.04.033
2020
Tan M, Mosaoa R, Graham GT, et al. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death Differ. 2020;27(7):2143-2157. doi:10.1038/s41418-020-0491-6
Parasido E, Avetian GS, Naeem A, et al. The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells. Mol Cancer Res. 2019;17(9):1815-1827. doi:10.1158/1541-7786.MCR-19-0191
Demby TC, Rodriguez O, McCarthy CW, et al. A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype. Behav Brain Res. 2020;384:112534. doi:10.1016/j.bbr.2020.112534
Speidell AP, Demby T, Lee Y, et al. Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res. 2019;35(2):291-303. doi:10.1007/s12640-018-9954-7
2018
Main BS, Villapol S, Sloley SS, et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. Mol Neurodegener. 2018;13(1):17. Published 2018 Apr 4. doi:10.1186/s13024-018-0249-5
Main BS, Villapol S, Sloley SS, et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. Mol Neurodegener. 2018;13(1):17. Published 2018 Apr 4. doi:10.1186/s13024-018-0249-5
Smith JP, Wang S, Nadella S, Jablonski SA, Weiner LM. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother. 2018;67(2):195-207. doi:10.1007/s00262-017-2077-9
2016
Hong SH, Tilan JU, Galli S, et al. In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis. J Vis Exp. 2016;(118):54532. Published 2016 Dec 9. doi:10.3791/54532
Galli S, Naranjo A, Van Ryn C, et al. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Am J Pathol. 2016;186(11):3040-3053. doi:10.1016/j.ajpath.2016.07.019
Allen M, Ghosh S, Ahern GP, Villapol S, Maguire-Zeiss KA, Conant K. Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1. Sci Rep. 2016;6:35497. Published 2016 Oct 20. doi:10.1038/srep35497
Çelik H, Bulut G, Han J, et al. Ezrin Inhibition Up-regulates Stress Response Gene Expression. J Biol Chem. 2016;291(25):13257-13270. doi:10.1074/jbc.M116.718189
Rodriguez O, Schaefer ML, Wester B, et al. Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury. J Neurotrauma. 2016;33(7):662-671. doi:10.1089/neu.2015.4002
2015
Kim SS, Rait A, Kim E, DeMarco J, Pirollo KF, Chang EH. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Cancer Lett. 2015;369(1):250-258. doi:10.1016/j.canlet.2015.08.022
Bhatia S, Hirsch K, Baig NA, et al. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model. J Hematol Oncol. 2015;8:105. Published 2015 Sep 7. doi:10.1186/s13045-015-0202-9
Credle JJ, George JL, Wills J, et al. GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death Differ. 2015;22(5):838-851. doi:10.1038/cdd.2014.179
Credle JJ, George JL, Wills J, et al. GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death Differ. 2015;22(5):838-851. doi:10.1038/cdd.2014.179
Hong SH, Tilan JU, Galli S, et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination – in vivo model of site-specific metastases. Oncotarget. 2015;6(9):7151-7165. doi:10.18632/oncotarget.3345
Kim SS, Rait A, Kim E, Pirollo KF, Chang EH. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Nanomedicine. 2015;11(2):301-311. doi:10.1016/j.nano.2014.09.005
2014
Tian Y, Wang SS, Zhang Z, et al. Integration of Network Biology and Imaging to Study Cancer Phenotypes and Responses. IEEE/ACM Trans Comput Biol Bioinform. 2014;11(6):1009-1019. doi:10.1109/TCBB.2014.2338304
Heier CR, Damsker JM, Yu Q, et al. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO Mol Med. 2013;5(10):1569-1585. doi:10.1002/emmm.201302621
Suman S, Rodriguez OC, Winters TA, Fornace AJ Jr, Albanese C, Datta K. Therapeutic and space radiation exposure of mouse brain causes impaired DNA repair response and premature senescence by chronic oxidant production. Aging (Albany NY). 2013;5(8):607-622. doi:10.18632/aging.100587
Albanese C, Rodriguez OC, VanMeter J, et al. Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges. Am J Pathol. 2013;182(2):312-318. doi:10.1016/j.ajpath.2012.09.024
2012
Sirajuddin P, Das S, Ringer L, et al. Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle. 2012;11(20):3801-3809. doi:10.4161/cc.21988
Piao CS, Loane DJ, Stoica BA, et al. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Neurobiol Dis. 2012;46(3):745-758. doi:10.1016/j.nbd.2012.03.018
Byrnes KR, Washington PM, Knoblach SM, Hoffman E, Faden AI. Delayed inflammatory mRNA and protein expression after spinal cord injury. J Neuroinflammation. 2011;8:130. Published 2011 Oct 5. doi:10.1186/1742-2094-8-130
Haggerty T, Credle J, Rodriguez O, et al. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease. Eur J Neurosci. 2011;33(9):1598-1610. doi:10.1111/j.1460-9568.2011.07660.x
Loane DJ, Washington PM, Vardanian L, et al. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma. 2011;28(2):225-236. doi:10.1089/neu.2010.1595
Beauchamp EM, Ringer L, Bulut G, et al. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J Clin Invest. 2011;121(1):148-160. doi:10.1172/JCI42874
Pollock CB, Rodriguez O, Martin PL, et al. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. PPAR Res. 2010;2010:571783. doi:10.1155/2010/571783
Cernak I, Chang T, Ahmed FA, et al. Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Dev Neurosci. 2010;32(5-6):442-453. doi:10.1159/000320085
2009
Byrnes KR, Stoica B, Riccio A, Pajoohesh-Ganji A, Loane DJ, Faden AI. Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann Neurol. 2009;66(1):63-74. doi:10.1002/ana.21673
Freedman M, Chang EH, Zhou Q, Pirollo KF. Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases. Acad Radiol. 2009;16(5):627-637. doi:10.1016/j.acra.2008.12.002
Loane DJ, Pocivavsek A, Moussa CE, et al. Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med. 2009;15(4):377-379. doi:10.1038/nm.1940
Byrnes KR, Loane DJ, Faden AI. Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics. 2009;6(1):94-107. doi:10.1016/j.nurt.2008.10.038
2006
Fricke ST, Rodriguez O, Vanmeter J, et al. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate. 2006;66(7):708-717. doi:10.1002/pros.20392
Rodriguez O, Fricke S, Chien C, et al. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle. 2006;5(1):113-119. doi:10.4161/cc.5.1.2295